aluates Reports

$ 0.0

Automative

Global Tick-borne Encephalitis Inactivated Vaccine Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-16Y7778

China Tick borne Encephalitis Inactivated Vaccine Market Report Forecast 2021 2027

BUY CHAPTERS

Global Tick-borne Encephalitis Inactivated Vaccine Market Research Report 2025

Code: QYRE-Auto-16Y7778

Report

August 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Encephalitis

Cochrane Collaboration

Sonic HealthPlus

Superdrug Health

Tick-borne Encephalitis Inactivated Vaccine Market Size

The global market for Tick-borne Encephalitis Inactivated Vaccine was valued at US$ 594 million in the year 2024 and is projected to reach a revised size of US$ 897 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Tick-borne Encephalitis Inactivated Vaccine Market

Tick-borne encephalitis vaccine is used against tick-borne encephalitis (TBE) virus, which spread by bites of virus-infected ticks, affecting brain and spinal cord. The major symptoms occurring as a result of TBE infection are headache, agitation, high temperature (fever), sickness (vomiting), and confusion.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tick-borne Encephalitis Inactivated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tick-borne Encephalitis Inactivated Vaccine.

The Tick-borne Encephalitis Inactivated Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tick-borne Encephalitis Inactivated Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tick-borne Encephalitis Inactivated Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tick-borne Encephalitis Inactivated Vaccine Market Report

Report Metric	Details
Report Name	Tick-borne Encephalitis Inactivated Vaccine Market
Accounted market size in year	US$ 594 million
Forecasted market size in 2031	US$ 897 million
CAGR	6.2%
Base Year	year
Forecasted years	2025 - 2031
by Type	European TBE Virus Far Eastern TBE Virus Siberian TBE Virus
by Application	Pediatric Vaccines Adult Vaccines Traveler Vaccines
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Encephalitis, Cochrane Collaboration, Sonic HealthPlus, Superdrug Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tick-borne Encephalitis Inactivated Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Tick-borne Encephalitis Inactivated Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Tick-borne Encephalitis Inactivated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Tick-borne Encephalitis Inactivated Vaccine Market growing?

Ans: The Tick-borne Encephalitis Inactivated Vaccine Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Tick-borne Encephalitis Inactivated Vaccine Market size in 2031?

Ans: The Tick-borne Encephalitis Inactivated Vaccine Market size in 2031 will be US$ 897 million.

Who are the main players in the Tick-borne Encephalitis Inactivated Vaccine Market report?

Ans: The main players in the Tick-borne Encephalitis Inactivated Vaccine Market are Pfizer, Encephalitis, Cochrane Collaboration, Sonic HealthPlus, Superdrug Health

What are the Application segmentation covered in the Tick-borne Encephalitis Inactivated Vaccine Market report?

Ans: The Applications covered in the Tick-borne Encephalitis Inactivated Vaccine Market report are Pediatric Vaccines, Adult Vaccines, Traveler Vaccines

What are the Type segmentation covered in the Tick-borne Encephalitis Inactivated Vaccine Market report?

Ans: The Types covered in the Tick-borne Encephalitis Inactivated Vaccine Market report are European TBE Virus, Far Eastern TBE Virus, Siberian TBE Virus

Recommended Reports

Pediatric & Preventable Vaccines

Encephalitis & Related Vaccines

Flu & Emerging Vaccines

1 Tick-borne Encephalitis Inactivated Vaccine Market Overview

1.1 Product Definition

1.2 Tick-borne Encephalitis Inactivated Vaccine by Type

1.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 European TBE Virus

1.2.3 Far Eastern TBE Virus

1.2.4 Siberian TBE Virus

1.3 Tick-borne Encephalitis Inactivated Vaccine by Application

1.3.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Pediatric Vaccines

1.3.3 Adult Vaccines

1.3.4 Traveler Vaccines

1.4 Global Market Growth Prospects

1.4.1 Global Tick-borne Encephalitis Inactivated Vaccine Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Tick-borne Encephalitis Inactivated Vaccine Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Tick-borne Encephalitis Inactivated Vaccine Production Estimates and Forecasts (2020-2031)

1.4.4 Global Tick-borne Encephalitis Inactivated Vaccine Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share by Manufacturers (2020-2025)

2.2 Global Tick-borne Encephalitis Inactivated Vaccine Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Tick-borne Encephalitis Inactivated Vaccine, Industry Ranking, 2023 VS 2024

2.4 Global Tick-borne Encephalitis Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Tick-borne Encephalitis Inactivated Vaccine Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Tick-borne Encephalitis Inactivated Vaccine, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Tick-borne Encephalitis Inactivated Vaccine, Product Offered and Application

2.8 Global Key Manufacturers of Tick-borne Encephalitis Inactivated Vaccine, Date of Enter into This Industry

2.9 Tick-borne Encephalitis Inactivated Vaccine Market Competitive Situation and Trends

2.9.1 Tick-borne Encephalitis Inactivated Vaccine Market Concentration Rate

2.9.2 Global 5 and 10 Largest Tick-borne Encephalitis Inactivated Vaccine Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Tick-borne Encephalitis Inactivated Vaccine Production by Region

3.1 Global Tick-borne Encephalitis Inactivated Vaccine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Region (2020-2031)

3.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Tick-borne Encephalitis Inactivated Vaccine by Region (2026-2031)

3.3 Global Tick-borne Encephalitis Inactivated Vaccine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Tick-borne Encephalitis Inactivated Vaccine Production Volume by Region (2020-2031)

3.4.1 Global Tick-borne Encephalitis Inactivated Vaccine Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Tick-borne Encephalitis Inactivated Vaccine by Region (2026-2031)

3.5 Global Tick-borne Encephalitis Inactivated Vaccine Market Price Analysis by Region (2020-2025)

3.6 Global Tick-borne Encephalitis Inactivated Vaccine Production and Value, Year-over-Year Growth

3.6.1 North America Tick-borne Encephalitis Inactivated Vaccine Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Tick-borne Encephalitis Inactivated Vaccine Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Tick-borne Encephalitis Inactivated Vaccine Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Tick-borne Encephalitis Inactivated Vaccine Production Value Estimates and Forecasts (2020-2031)

4 Tick-borne Encephalitis Inactivated Vaccine Consumption by Region

4.1 Global Tick-borne Encephalitis Inactivated Vaccine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Tick-borne Encephalitis Inactivated Vaccine Consumption by Region (2020-2031)

4.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Consumption by Region (2020-2025)

4.2.2 Global Tick-borne Encephalitis Inactivated Vaccine Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Tick-borne Encephalitis Inactivated Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Tick-borne Encephalitis Inactivated Vaccine Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Tick-borne Encephalitis Inactivated Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Tick-borne Encephalitis Inactivated Vaccine Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Tick-borne Encephalitis Inactivated Vaccine Production by Type (2020-2031)

5.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Production by Type (2020-2025)

5.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Production by Type (2026-2031)

5.1.3 Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share by Type (2020-2031)

5.2 Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Type (2020-2031)

5.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Type (2020-2025)

5.2.2 Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Type (2026-2031)

5.2.3 Global Tick-borne Encephalitis Inactivated Vaccine Production Value Market Share by Type (2020-2031)

5.3 Global Tick-borne Encephalitis Inactivated Vaccine Price by Type (2020-2031)

6 Segment by Application

6.1 Global Tick-borne Encephalitis Inactivated Vaccine Production by Application (2020-2031)

6.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Production by Application (2020-2025)

6.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Production by Application (2026-2031)

6.1.3 Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share by Application (2020-2031)

6.2 Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Application (2020-2031)

6.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Application (2020-2025)

6.2.2 Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Application (2026-2031)

6.2.3 Global Tick-borne Encephalitis Inactivated Vaccine Production Value Market Share by Application (2020-2031)

6.3 Global Tick-borne Encephalitis Inactivated Vaccine Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Pfizer

7.1.1 Pfizer Tick-borne Encephalitis Inactivated Vaccine Company Information

7.1.2 Pfizer Tick-borne Encephalitis Inactivated Vaccine Product Portfolio

7.1.3 Pfizer Tick-borne Encephalitis Inactivated Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Pfizer Main Business and Markets Served

7.1.5 Pfizer Recent Developments/Updates

7.2 Encephalitis

7.2.1 Encephalitis Tick-borne Encephalitis Inactivated Vaccine Company Information

7.2.2 Encephalitis Tick-borne Encephalitis Inactivated Vaccine Product Portfolio

7.2.3 Encephalitis Tick-borne Encephalitis Inactivated Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Encephalitis Main Business and Markets Served

7.2.5 Encephalitis Recent Developments/Updates

7.3 Cochrane Collaboration

7.3.1 Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Company Information

7.3.2 Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Product Portfolio

7.3.3 Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Cochrane Collaboration Main Business and Markets Served

7.3.5 Cochrane Collaboration Recent Developments/Updates

7.4 Sonic HealthPlus

7.4.1 Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Company Information

7.4.2 Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Product Portfolio

7.4.3 Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Sonic HealthPlus Main Business and Markets Served

7.4.5 Sonic HealthPlus Recent Developments/Updates

7.5 Superdrug Health

7.5.1 Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Company Information

7.5.2 Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Product Portfolio

7.5.3 Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Superdrug Health Main Business and Markets Served

7.5.5 Superdrug Health Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Tick-borne Encephalitis Inactivated Vaccine Industry Chain Analysis

8.2 Tick-borne Encephalitis Inactivated Vaccine Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Tick-borne Encephalitis Inactivated Vaccine Production Mode & Process Analysis

8.4 Tick-borne Encephalitis Inactivated Vaccine Sales and Marketing

8.4.1 Tick-borne Encephalitis Inactivated Vaccine Sales Channels

8.4.2 Tick-borne Encephalitis Inactivated Vaccine Distributors

8.5 Tick-borne Encephalitis Inactivated Vaccine Customer Analysis

9 Tick-borne Encephalitis Inactivated Vaccine Market Dynamics

9.1 Tick-borne Encephalitis Inactivated Vaccine Industry Trends

9.2 Tick-borne Encephalitis Inactivated Vaccine Market Drivers

9.3 Tick-borne Encephalitis Inactivated Vaccine Market Challenges

9.4 Tick-borne Encephalitis Inactivated Vaccine Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Encephalitis

Cochrane Collaboration

Sonic HealthPlus

Superdrug Health

List of Tables

Table 1. Global Tick-borne Encephalitis Inactivated Vaccine Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Tick-borne Encephalitis Inactivated Vaccine Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Tick-borne Encephalitis Inactivated Vaccine Production Capacity (K Units) by Manufacturers in 2024

Table 4. Global Tick-borne Encephalitis Inactivated Vaccine Production by Manufacturers (2020-2025) & (K Units)

Table 5. Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share by Manufacturers (2020-2025)

Table 6. Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Tick-borne Encephalitis Inactivated Vaccine Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Tick-borne Encephalitis Inactivated Vaccine, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Tick-borne Encephalitis Inactivated Vaccine as of 2024)

Table 10. Global Market Tick-borne Encephalitis Inactivated Vaccine Average Price by Manufacturers (USD/Unit) & (2020-2025)

Table 11. Global Key Manufacturers of Tick-borne Encephalitis Inactivated Vaccine, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Tick-borne Encephalitis Inactivated Vaccine, Product Offered and Application

Table 13. Global Key Manufacturers of Tick-borne Encephalitis Inactivated Vaccine, Date of Enter into This Industry

Table 14. Global Tick-borne Encephalitis Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Tick-borne Encephalitis Inactivated Vaccine Production Value Market Share by Region (2020-2025)

Table 19. Global Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Tick-borne Encephalitis Inactivated Vaccine Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Tick-borne Encephalitis Inactivated Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Tick-borne Encephalitis Inactivated Vaccine Production (K Units) by Region (2020-2025)

Table 23. Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share by Region (2020-2025)

Table 24. Global Tick-borne Encephalitis Inactivated Vaccine Production (K Units) Forecast by Region (2026-2031)

Table 25. Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share Forecast by Region (2026-2031)

Table 26. Global Tick-borne Encephalitis Inactivated Vaccine Market Average Price (USD/Unit) by Region (2020-2025)

Table 27. Global Tick-borne Encephalitis Inactivated Vaccine Market Average Price (USD/Unit) by Region (2026-2031)

Table 28. Global Tick-borne Encephalitis Inactivated Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)

Table 29. Global Tick-borne Encephalitis Inactivated Vaccine Consumption by Region (2020-2025) & (K Units)

Table 30. Global Tick-borne Encephalitis Inactivated Vaccine Consumption Market Share by Region (2020-2025)

Table 31. Global Tick-borne Encephalitis Inactivated Vaccine Forecasted Consumption by Region (2026-2031) & (K Units)

Table 32. Global Tick-borne Encephalitis Inactivated Vaccine Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Tick-borne Encephalitis Inactivated Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 34. North America Tick-borne Encephalitis Inactivated Vaccine Consumption by Country (2020-2025) & (K Units)

Table 35. North America Tick-borne Encephalitis Inactivated Vaccine Consumption by Country (2026-2031) & (K Units)

Table 36. Europe Tick-borne Encephalitis Inactivated Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 37. Europe Tick-borne Encephalitis Inactivated Vaccine Consumption by Country (2020-2025) & (K Units)

Table 38. Europe Tick-borne Encephalitis Inactivated Vaccine Consumption by Country (2026-2031) & (K Units)

Table 39. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)

Table 40. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Consumption by Region (2020-2025) & (K Units)

Table 41. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Consumption by Region (2026-2031) & (K Units)

Table 42. Latin America, Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 43. Latin America, Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Consumption by Country (2020-2025) & (K Units)

Table 44. Latin America, Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Consumption by Country (2026-2031) & (K Units)

Table 45. Global Tick-borne Encephalitis Inactivated Vaccine Production (K Units) by Type (2020-2025)

Table 46. Global Tick-borne Encephalitis Inactivated Vaccine Production (K Units) by Type (2026-2031)

Table 47. Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share by Type (2020-2025)

Table 48. Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share by Type (2026-2031)

Table 49. Global Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Tick-borne Encephalitis Inactivated Vaccine Production Value Market Share by Type (2020-2025)

Table 52. Global Tick-borne Encephalitis Inactivated Vaccine Production Value Market Share by Type (2026-2031)

Table 53. Global Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Type (2020-2025)

Table 54. Global Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Type (2026-2031)

Table 55. Global Tick-borne Encephalitis Inactivated Vaccine Production (K Units) by Application (2020-2025)

Table 56. Global Tick-borne Encephalitis Inactivated Vaccine Production (K Units) by Application (2026-2031)

Table 57. Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share by Application (2020-2025)

Table 58. Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share by Application (2026-2031)

Table 59. Global Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Tick-borne Encephalitis Inactivated Vaccine Production Value Market Share by Application (2020-2025)

Table 62. Global Tick-borne Encephalitis Inactivated Vaccine Production Value Market Share by Application (2026-2031)

Table 63. Global Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Application (2020-2025)

Table 64. Global Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Application (2026-2031)

Table 65. Pfizer Tick-borne Encephalitis Inactivated Vaccine Company Information

Table 66. Pfizer Tick-borne Encephalitis Inactivated Vaccine Specification and Application

Table 67. Pfizer Tick-borne Encephalitis Inactivated Vaccine Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 68. Pfizer Main Business and Markets Served

Table 69. Pfizer Recent Developments/Updates

Table 70. Encephalitis Tick-borne Encephalitis Inactivated Vaccine Company Information

Table 71. Encephalitis Tick-borne Encephalitis Inactivated Vaccine Specification and Application

Table 72. Encephalitis Tick-borne Encephalitis Inactivated Vaccine Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Encephalitis Main Business and Markets Served

Table 74. Encephalitis Recent Developments/Updates

Table 75. Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Company Information

Table 76. Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Specification and Application

Table 77. Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Cochrane Collaboration Main Business and Markets Served

Table 79. Cochrane Collaboration Recent Developments/Updates

Table 80. Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Company Information

Table 81. Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Specification and Application

Table 82. Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Sonic HealthPlus Main Business and Markets Served

Table 84. Sonic HealthPlus Recent Developments/Updates

Table 85. Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Company Information

Table 86. Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Specification and Application

Table 87. Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Superdrug Health Main Business and Markets Served

Table 89. Superdrug Health Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Tick-borne Encephalitis Inactivated Vaccine Distributors List

Table 93. Tick-borne Encephalitis Inactivated Vaccine Customers List

Table 94. Tick-borne Encephalitis Inactivated Vaccine Market Trends

Table 95. Tick-borne Encephalitis Inactivated Vaccine Market Drivers

Table 96. Tick-borne Encephalitis Inactivated Vaccine Market Challenges

Table 97. Tick-borne Encephalitis Inactivated Vaccine Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Tick-borne Encephalitis Inactivated Vaccine

Figure 2. Global Tick-borne Encephalitis Inactivated Vaccine Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Tick-borne Encephalitis Inactivated Vaccine Market Share by Type: 2024 VS 2031

Figure 4. European TBE Virus Product Picture

Figure 5. Far Eastern TBE Virus Product Picture

Figure 6. Siberian TBE Virus Product Picture

Figure 7. Global Tick-borne Encephalitis Inactivated Vaccine Market Value by Application, (US$ Million) & (2020-2031)

Figure 8. Global Tick-borne Encephalitis Inactivated Vaccine Market Share by Application: 2024 VS 2031

Figure 9. Pediatric Vaccines

Figure 10. Adult Vaccines

Figure 11. Traveler Vaccines

Figure 12. Global Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) & (2020-2031)

Figure 14. Global Tick-borne Encephalitis Inactivated Vaccine Production Capacity (K Units) & (2020-2031)

Figure 15. Global Tick-borne Encephalitis Inactivated Vaccine Production (K Units) & (2020-2031)

Figure 16. Global Tick-borne Encephalitis Inactivated Vaccine Average Price (USD/Unit) & (2020-2031)

Figure 17. Tick-borne Encephalitis Inactivated Vaccine Report Years Considered

Figure 18. Tick-borne Encephalitis Inactivated Vaccine Production Share by Manufacturers in 2024

Figure 19. Global Tick-borne Encephalitis Inactivated Vaccine Production Value Share by Manufacturers (2024)

Figure 20. Tick-borne Encephalitis Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. The Global 5 and 10 Largest Players: Market Share by Tick-borne Encephalitis Inactivated Vaccine Revenue in 2024

Figure 22. Global Tick-borne Encephalitis Inactivated Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 23. Global Tick-borne Encephalitis Inactivated Vaccine Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 24. Global Tick-borne Encephalitis Inactivated Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 25. Global Tick-borne Encephalitis Inactivated Vaccine Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 26. North America Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. Europe Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. China Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Japan Tick-borne Encephalitis Inactivated Vaccine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. Global Tick-borne Encephalitis Inactivated Vaccine Consumption by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 31. Global Tick-borne Encephalitis Inactivated Vaccine Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 32. North America Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 33. North America Tick-borne Encephalitis Inactivated Vaccine Consumption Market Share by Country (2020-2031)

Figure 34. U.S. Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 35. Canada Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 36. Europe Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 37. Europe Tick-borne Encephalitis Inactivated Vaccine Consumption Market Share by Country (2020-2031)

Figure 38. Germany Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 39. France Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 40. U.K. Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 41. Italy Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 42. Russia Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 43. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 44. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Consumption Market Share by Region (2020-2031)

Figure 45. China Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 46. Japan Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 47. South Korea Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 48. China Taiwan Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 49. Southeast Asia Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 50. India Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 51. Latin America, Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 52. Latin America, Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Consumption Market Share by Country (2020-2031)

Figure 53. Mexico Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 54. Brazil Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 55. Turkey Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 56. GCC Countries Tick-borne Encephalitis Inactivated Vaccine Consumption and Growth Rate (2020-2031) & (K Units)

Figure 57. Global Production Market Share of Tick-borne Encephalitis Inactivated Vaccine by Type (2020-2031)

Figure 58. Global Production Value Market Share of Tick-borne Encephalitis Inactivated Vaccine by Type (2020-2031)

Figure 59. Global Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Type (2020-2031)

Figure 60. Global Production Market Share of Tick-borne Encephalitis Inactivated Vaccine by Application (2020-2031)

Figure 61. Global Production Value Market Share of Tick-borne Encephalitis Inactivated Vaccine by Application (2020-2031)

Figure 62. Global Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Application (2020-2031)

Figure 63. Tick-borne Encephalitis Inactivated Vaccine Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lyme Disease Vaccine Market Research Report 2025

Encephalitis Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Lyme Disease Vaccine Market Research Report 2024

Global Tick borne Encephalitis Virus Nucleic Acid Detection Kit Market Research Report 2024

Swine Epidemic Encephalitis Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Live Attenuated Japanese Encephalitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Japanese Encephalitis Vaccines Market Research Report 2024

Global Japanese Encephalitis Inactivated Vaccine Market Research Report 2025

Meningitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dengue Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tetanus Vaccine Market Insights Forecast to 2030

Global TB Disease Vaccine Market Research Report 2025

Global Poultry Killed Vaccines Market Research Report 2025

Dengvaxia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global BCG Vaccine Market Insights Forecast to 2030

Global Bacille Calmette Guerin Vaccine Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions